Darwin AG will participate in two capital markets conferences in spring 2026, presenting at the Invest conference in Stuttgart and the Equity Forum German Spring Conference in Frankfurt. At both events, management will present the company's equity story and recent developments while being available for one-on-one meetings. These appearances signal Darwin AG's continued engagement with both retail and institutional investment communities during a period when the company is advancing its position in personalized healthcare.
The Invest conference, described as the leading expo for finance and investment, will take place from April 17 to 18, 2026, at Messe Stuttgart and targets retail investors. CEO Dr. Daniel Wallerstorfer will present under the theme "Invest in the Future of Precision Health" on April 17 at 5:30 p.m., providing insight into how personalized solutions are shaping tomorrow's healthcare market. Visitors can meet management at Hall 4, Booth 4E32 to learn about personalized health and Darwin AG products. Further information about Invest can be found here.
The Equity Forum's 2026 Spring Conference, a MiFID II-compliant professional event for institutional investors, analysts, and venture capital investors, will occur from May 11 to 12 at the Flemings Selection Hotel in Frankfurt. Darwin AG will present a corporate update and audited financial results for 2025 to investors, analysts, and financial journalists, along with operational and strategic outlook. The 2025 consolidated financial statements will be published in the Annual Report on May 12, 2026.
The presentation at the Equity Forum will take place on May 12 from 9:20 a.m. to 9:55 a.m., followed by one-on-one meetings with CEO Dr. Daniel Wallerstorfer. Individual meetings can be scheduled via the event tool on the conference website. More information about the 2026 German Spring Conference can be found here.
The dual-conference approach allows the company to address different investor segments while maintaining consistent messaging about its genetic analysis-based products and services. The release of 2025 financial results at the Equity Forum provides institutional investors with timely access to audited performance data alongside strategic updates. This coordinated outreach effort demonstrates Darwin AG's commitment to transparent communication with the investment community as it executes its growth strategy in the precision health sector.
